CADA—computer-aided DaTSCAN analysis

BackgroundDopamine transporter (DaT) imaging (DaTSCAN) is useful for the differential diagnosis of parkinsonian syndromes. Visual evaluation of DaTSCAN images represents the generally accepted diagnostic method, but it is strongly dependent on the observer’s experience and shows inter- and intra-observer variability. A reliable and automatic method for DaTSCAN evaluation can provide objective quantification; it is desirable for longitudinal studies, and it allows for a better follow-up control. Moreover, it is crucial for an automated method to produce coherent measures related to the severity of motor symptoms.MethodsIn this work, we propose a novel fully automated technique for DaTSCAN analysis that generates quantitative measures based on striatal intensity, shape, symmetry and extent. We tested these measures using a support vector machine (SVM) classifier.ResultsThe proposed measures reached 100 % accuracy in distinguishing between patients with Parkinson’s disease (PD) and control subjects. We also demonstrate the existence of a linear relationship and an exponential trend between pooled structural and functional striatal characteristics and the Unified Parkinson’s disease Rating Scale (UPDRS) motor score.ConclusionsWe present a novel, highly reproducible, user-independent technique for DaTSCAN analysis producing quantitative measures directly connected to striatum uptake and shape. In our method, no a priori assumption is required on the spatial conformation and localization of striatum, and both uptake and symmetry contribute to the index quantification. These measures can reliably support a computer-assisted decision system.

[1]  Perry E Radau,et al.  Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  Christopher G. Goetz Chairperson,et al.  Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease , 2004 .

[3]  Claus Svarer,et al.  MRI-Guided Region-of-Interest Delineation Is Comparable to Manual Delineation in Dopamine Transporter SPECT Quantification in Patients: A Reproducibility Study , 2010, Journal of Nuclear Medicine Technology.

[4]  H. Kung,et al.  Imaging of dopamine transporters in humans with technetium-99m TRODAT 1 , 1996, European Journal of Nuclear Medicine.

[5]  Juan Manuel Górriz,et al.  Bilateral symmetry aspects in computer-aided Alzheimer's disease diagnosis by single-photon emission-computed tomography imaging , 2012, Artif. Intell. Medicine.

[6]  I G McKeith,et al.  Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. , 1999, Brain : a journal of neurology.

[7]  Javier Ramírez,et al.  Linear intensity normalization of FP-CIT SPECT brain images using the α-stable distribution , 2013, NeuroImage.

[8]  F Segovia,et al.  Improved Parkinsonism diagnosis using a partial least squares based approach. , 2012, Medical physics.

[9]  Roongroj Bhidayasiri How useful is (123I) beta-CIT SPECT in the diagnosis of Parkinson's disease? , 2006, Reviews in neurological diseases.

[10]  Zoe Katsarou,et al.  [Findings from molecular imaging with SPET camera and 123I-ioflupane in the differential diagnosis of Parkinsonism and essential tremor]. , 2005, Hellenic journal of nuclear medicine.

[11]  M. A. Balafar,et al.  Gaussian mixture model based segmentation methods for brain MRI images , 2012, Artificial Intelligence Review.

[12]  Andrea Skanjeti,et al.  Multicenter Semiquantitative Evaluation of 123I‐FP‐CIT Brain SPECT , 2015, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[13]  F J Martinez-Murcia,et al.  Parametrization of textural patterns in 123I-ioflupane imaging for the automatic detection of Parkinsonism. , 2014, Medical physics.

[14]  J. Jankovic,et al.  Essential tremor and parkinson's disease , 1989, Annals of neurology.

[15]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[16]  Donald Grosset,et al.  Role of dopamine transporter imaging in routine clinical practice , 2003, Movement disorders : official journal of the Movement Disorder Society.

[17]  J. Jankovic Parkinson’s disease: clinical features and diagnosis , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[18]  K. Jellinger,et al.  Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.

[19]  Kimihiko Abe,et al.  New semiquantitative assessment of123I-FP-CIT by an anatomical standardization method , 2006, Annals of Nuclear Medicine.

[20]  Peter C. Meltzer,et al.  Imaging of dopamine transporters in humans with technetium-99m TRODAT-1 , 2004, European Journal of Nuclear Medicine.

[21]  Piero Calvini,et al.  The basal ganglia matching tools package for striatal uptake semi-quantification: description and validation , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[22]  Koen Van Laere,et al.  EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2 , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[23]  Susanne Klutmann,et al.  Impact of DaTscan SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use and safety in patients with clinically uncertain parkinsonian syndromes: a prospective 1-year follow-up of an open-label controlled study , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[24]  Pablo Aguiar,et al.  Validation of semi-quantitative methods for DAT SPECT: influence of anatomical variability and partial volume effect , 2015, Physics in medicine and biology.

[25]  S. Asenbaum,et al.  [123I]β-CIT and SPECT in essential tremor and Parkinson's disease , 1998, Journal of Neural Transmission.

[26]  W. Pirker,et al.  Correlation of dopamine transporter imaging with parkinsonian motor handicap: How close is it? , 2003, Movement disorders : official journal of the Movement Disorder Society.

[27]  Chih-Jen Lin,et al.  LIBSVM: A library for support vector machines , 2011, TIST.

[28]  Rene Donner,et al.  Fully automated 3D basal ganglia activity measurement in dopamine transporter scintigraphy (Spectalyzer) , 2010, Annals of nuclear medicine.

[29]  R. Okafor Maximum likelihood estimation from incomplete data , 1987 .

[30]  John S. Fleming,et al.  Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[31]  Stephen M. Smith,et al.  A global optimisation method for robust affine registration of brain images , 2001, Medical Image Anal..

[32]  Nikolaos Karatzas,et al.  SPECT imaging evaluation in movement disorders: far beyond visual assessment , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[33]  Perry E. Radau,et al.  Does combined imaging of the pre- and postsynaptic dopaminergic system increase the diagnostic accuracy in the differential diagnosis of parkinsonism? , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[34]  D J Wyper,et al.  Correlation of Parkinson's disease severity and duration with 123I‐FP‐CIT SPECT striatal uptake , 2000, Movement disorders : official journal of the Movement Disorder Society.

[35]  J. Jankovic,et al.  Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Process, format, and clinimetric testing plan , 2007, Movement disorders : official journal of the Movement Disorder Society.

[36]  Michael Brady,et al.  Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images , 2002, NeuroImage.

[37]  M. Kaufman,et al.  Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's‐diseased striatum , 1991, Synapse.

[38]  John Seibyl,et al.  SNM Practice Guideline for Dopamine Transporter Imaging with 123I-Ioflupane SPECT 1.0* , 2012, The Journal of Nuclear Medicine.

[39]  M Laruelle,et al.  Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Hong Zhang,et al.  SPECT Molecular Imaging in Parkinson's Disease , 2012, Journal of biomedicine & biotechnology.